Scripps VIVO scripps research logo

  • Index
  • Log in
  • Home
  • People
  • Organizations
  • Research
  • Events
Search form

Academic Article RDF

  • 32
  • 33
  • 34
  • 35
  • 36
  • 37
  • 38
  • 39
  • 40
  • 41
  • 42
  • 43
  • 44
  • 45
  • 46
  • 47
  • 48
  • 49
  • 50
  • 51
  • 52
  • 53
  • 54
  • 55
  • 56
  • 57
  • 58
  • 59
  • 60
  • 61
  • 62
  • 63
  • 64
  • 65
  • 66
  • 67
  • 68
  • 69
  • 70
  • 71
  • 72
  • more...
  • A new species of Eimeria from the golden-mantled ground squirrel, Spermophilus lateralis, in Northern Colorado
  • A new stereoisomer of stemmadenine alkaloid from Tabernaemontana heyneana
  • A new strategy for directed protein cleavage
  • A new strategy for full control of relative stereochemistry expands the role of asymmetric-synthesis
  • A new strategy for glycoprotein synthesis: ligation of synthetic glycopeptides with truncated proteins expressed in E. coli as TEV protease cleavable fusion protein
  • A new strategy for improved nicotine vaccines using conformationally constrained haptens
  • A new strategy for selective protein cleavage
  • A new strategy for smoking cessation: characterization of a bacterial enzyme for the degradation of nicotine
  • A new strategy for the cloning, overexpression and one-step purification of 3 dhap-dependent aldolases - rhamnulose-1-phosphate aldolase, fuculose-1-phosphate aldolase and tagatose-1,6-diphosphate aldolase
  • A new strategy for the generation of catalytic antibodies
  • A new strategy for the site-specific modification of proteins in vivo
  • A new strategy for the synthesis of glycoproteins
  • A new strategy for the synthesis of nucleoside analogs based on enzyme-catalyzed aldol reactions
  • A new strategy to photoactivate green fluorescent protein
  • A new structural framework for integrating replication protein A into DNA processing machinery
  • A new synthesis of lysergic acid
  • A new synthesis of peptidyl epoxysuccinates for probing cysteine protease-inhibitor p-3/s-3 binding interactions
  • A new synthetic approach toward bacterial transglycosylase substrates, lipid ii and lipid iv
  • A new system for naming ribosomal proteins
  • A new TLR2 agonist promotes cross-presentation by mouse and human antigen presenting cells
  • A new tool for studying protein-structure and function
  • A new troponin T and cDNA clones for 13 different muscle proteins, found by shotgun sequencing
  • A new UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase mRNA exhibits predominant expression in the hypothalamus, thalamus and amygdala of mouse forebrain
  • A new variant of type II von Willebrand disease with aberrant multimeric structure of plasma but not platelet von Willebrand factor (type IIF)
  • A new versatile system for rapid control of gene expression in the fission yeast Schizosaccharomyces pombe
  • A new visual screening assay for catalytic antibodies with retro-aldol retro-michael activity
  • A new world order: tailored gene targeting and regulation using CRISPR
  • A New World primate deficient in tetherin-mediated restriction of human immunodeficiency virus type 1
  • A new, short, and stereocontrolled synthesis of C-2 -symmetric 1,2-diamines
  • A newly isolated avian-sarcoma virus, asv-1, carries the crk oncogene
  • 32
  • 33
  • 34
  • 35
  • 36
  • 37
  • 38
  • 39
  • 40
  • 41
  • 42
  • 43
  • 44
  • 45
  • 46
  • 47
  • 48
  • 49
  • 50
  • 51
  • 52
  • 53
  • 54
  • 55
  • 56
  • 57
  • 58
  • 59
  • 60
  • 61
  • 62
  • 63
  • 64
  • 65
  • 66
  • 67
  • 68
  • 69
  • 70
  • 71
  • 72
  • more...

©2021 The Scripps Research Institute | Terms of Use | Powered by VIVO

  • About
  • Contact Us
  • Support